AXIM BIOTECHNOLOGIES, INC. Increase (Decrease) in Other Current Assets
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Increase (Decrease) in Other Current Assets of $9.82 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2024-04-16
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in other current assets for the quarter ending 2023-12-31 was $16.64K, a 878.01% increase year-over-year.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in other current assets for the quarter ending 2023-09-30 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in other current assets for the quarter ending 2023-06-30 was $4.01K.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in other current assets for the quarter ending 2023-03-31 was -$10.82K.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in other current assets for fiscal 2023 was $9.82K, a 477.60% increase from fiscal 2022.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in other current assets for fiscal 2022 was $1.70K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month | Increase (Decrease) in Other Current Assets 34 month |
|---|---|---|---|---|---|
| 2023-12-31 | $16.64K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $16.64K derived: sum of 2 quarters · filed 2024-04-16 | $20.65K derived: sum of 3 quarters · filed 2024-04-16 | $9.82K 10-K · filed 2024-04-16 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $4.01K derived: sum of 2 quarters · filed 2023-11-20 | -$6.81K 10-Q · filed 2023-11-20 | -$5.11K derived: sum of 4 quarters · filed 2024-04-16 | |
| 2023-06-30 | $4.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | -$6.81K 10-Q · filed 2023-08-21 | -$5.11K derived: sum of 3 quarters · filed 2024-04-16 | ||
| 2023-03-31 | -$10.82K 10-Q · filed 2023-05-22 | -$9.12K derived: sum of 2 quarters · filed 2024-04-16 | |||
| 2022-12-31 | $1.70K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $1.70K 10-K · filed 2024-04-16 | |||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-20 | ||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-22 | ||||
| 2013-09-30 | -$7.50K 10-Q · filed 2013-11-18 | -$7.50K 10-Q · filed 2013-11-18 |